Vericel (VCEL) Other Working Capital Changes (2010 - 2026)
Vericel (VCEL) reported Other Working Capital Changes of $246000.0 for Q1 2026, down 80.02% on a YoY basis from $1.2 million in Q1 2025, and up 193.89% sequentially from -$262000.0 in Q4 2025.
Vericel (VCEL) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Other Working Capital Changes data on file, last reported at $246000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 80.02% year-over-year to $246000.0; the trailing twelve-month figure through Mar 2026 stood at -$528000.0 (down 171.06% YoY), and the FY2025 full-year result was $457000.0, up 5.3% from the prior year.
- Other Working Capital Changes retreated to -$111000.0 in Q3 2019, from $141000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $141000.0 in Q2 2019 to a low of -$158000.0 in Q2 2018.
- A 5-year average of $21857.1 and a median of $37000.0 in 2015 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 450.57% in 2024, while the deepest fall reached 366.47% in 2024.
- Tracing VCEL's Other Working Capital Changes over 5 years: stood at $51000.0 in 2015, then plunged by 147.06% to -$24000.0 in 2016, then sank by 33.33% to -$32000.0 in 2017, then surged by 456.25% to $114000.0 in 2018, then plunged by 197.37% to -$111000.0 in 2019.
- Business Quant data shows VCEL's Other Working Capital Changes at -$111000.0 in Q3 2019, $141000.0 in Q2 2019, and $46000.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 246,000.00 |
| Mar 31, 2026 | 246,000.00 |
| Mar 31, 2026 | 246,000.00 |
| Dec 31, 2025 | -262,000.00 |
| Dec 31, 2025 | -262,000.00 |
| Dec 31, 2025 | -262,000.00 |
| Sep 30, 2025 | 1.43 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | -595,000.00 |
| Dec 31, 2024 | -595,000.00 |
| Dec 31, 2024 | -595,000.00 |
| Sep 30, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.45 Mn |